ArticleMcGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students2007
'Miracle stents'--a future without restenosis.
Article in McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.
- Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease.The Cochrane database of systematic reviews · 2013Pooled it
- Optimize PLA/EVA Polymers Blend Compositional Coating for Next Generation Biodegradable Drug-Eluting Stents.Polymers · 2022Article
- Delivery of Cinnamic Aldehyde Antioxidant Response Activating nanoParticles (ARAPas) for Vascular Applications.Antioxidants (Basel, Switzerland) · 2021Article
- Mechanistic evaluation of long-term in-stent restenosis based on models of tissue damage and growth.Biomechanics and modeling in mechanobiology · 2020Article
- Inhibition of Platelet Adhesion from Surface Modified Polyurethane Membranes.Biomedical journal of scientific & technical research · 2020Article
- Circulating microRNAs as possible biomarkers for coronary artery disease: a narrative review.EJIFCC · 2019Review
- The Effect of Mechanical Overloading on Surface Roughness of the Coronary Arteries.Applied bionics and biomechanics · 2019Article
- Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine.Drug delivery and translational research · 2018Review
- Article
- Shape Memory Polymers Containing Higher Acrylate Content Display Increased Endothelial Cell Attachment.Polymers · 2017Article
- Surface modification of endovascular stents with rosuvastatin and heparin-loaded biodegradable nanofibers by electrospinning.International journal of nanomedicine · 2017Article
- MgNd2 alloy in contact with nasal mucosa: an in vivo and in vitro approach.Journal of materials science. Materials in medicine · 2016Article
- Bioresorbable vascular scaffolds technology: current use and future developments.Medical devices (Auckland, N.Z.) · 2016Review
- Endothelial responses of magnesium and other alloying elements in magnesium-based stent materials.Metallomics : integrated biometal science · 2015Article
- Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution?Molecules (Basel, Switzerland) · 2014Review
- An agent-based model of the response to angioplasty and bare-metal stent deployment in an atherosclerotic blood vessel.PloS one · 2014Article
- Modelling the effect of a functional endothelium on the development of in-stent restenosis.PloS one · 2013Article
- Neointimal hyperplasia, vein graft remodeling, and long-term patency.American journal of physiology. Heart and circulatory physiology · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the last three decades, percutaneous coronary intervention (PCI) technology has revolutionized the field of cardiology. PCI began in the form of balloon angioplasty, and was followed by coronary stenting. In-Stent restenosis is the main limitation of coronary stenting, and has been delayed to some extent by the development of drug eluting stents. Coronary angioplasty with stenting is currently the most popular non-medical treatment of coronary artery disease therefore solving the problem of in-stent restenosis could change the future role of other types of coronary intervention. This review examines the types of percutaneous coronary interventions, the mechanisms leading up to in-stent restenosis, and how previous and current treatments of in-stent restenosis influence the vascular response to injury.
Identifiers
18523610PMC2323487W30979096What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.